Brefeldin A is an estrogenic, Erk1/2-activating component in the extract of Agaricus blazei mycelia

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 1, 2013, Pages 128-136

  Dong, Sijun ^a,b,c   Furutani, Yoshiyuki ^b   Kimura, Sadao ^d   Zhu, Yun ^a   Kawabata, Kazutaka ^a   Furutani, Michiko ^b   Nishikawa, Toshio ^b   Tanaka, Takeshi ^b   Masaki, Tomoh ^b   Matsuoka, Rumiko ^b   Kiyama, Ryoiti ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BLAZEI; BREAST CANCER; ESTROGENIC ACTIVITIES; FRUITING BODIES; FUNCTIONAL FOODS; MCF-7 CELLS; REPORTER GENE ASSAYS; SIGNALING PATHWAYS;

CHEMICAL ACTIVATION; GENES;

TRANSCRIPTION;

BREFELDIN A; ESTROGEN; PRIMER DNA;

AGARICUS; ARTICLE; CHEMISTRY; DNA MICROARRAY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGARICUS; BASE SEQUENCE; BLOTTING, WESTERN; BREFELDIN A; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; ESTROGENS; MAP KINASE SIGNALING SYSTEM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AGARICUS BLAZEI;

EID: 84872120636     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf304546a     Document Type: Article

References (54)

1. Tian, X.; Lun, Z.; Wang, J.; Ito, H.; Simura, K. Clinical observation on treatment of acute nonlymphocytic leukemia with Agaricus blazei Murill J. Lanzhou Med. College 1994, 169-171
2. Ahn, W. S.; Kim, D. J.; Chae, G. T.; Lee, J. M.; Bae, S. M.; Sin, J. I.; Kim, Y. W.; Namkoong, S. E.; Lee, I. P. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy Int. J. Gynecol. Cancer 2004, 14, 589-594
3. Hetland, G.; Sandven, P. β-1,3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures FEMS Immunol. Med. Microbiol. 2002, 33, 41-45
4. Morikawa, K.; Takeda, R.; Yamazaki, M.; Mizuno, D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3- d -glucan and other immunomodulators in murine cells Cancer Res. 1985, 45, 1496-1501
5. Kobayashi, H.; Yoshida, R.; Kanada, Y.; Fukuda, Y.; Yagyu, T.; Inagaki, K.; Kondo, T.; Kurita, N.; Suzuki, M.; Kanayama, N.; Terao, T. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model J. Cancer Res. Clin. Oncol. 2005, 131, 527-538
6. Itoh, H.; Ito, H.; Hibasami, H. Blazein of a new steroid isolated from Agaricus blazei Murrill (himematsutake) induces cell death and morphological change indicative of apoptotic chromatin condensation in human lung cancer LU99 and stomach cancer KATO III cells Oncol. Rep. 2008, 20, 1359-1361
7. Niu, Y. C.; Liu, J. C.; Zhao, X. M.; Wu, X. X. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo Oncol. Rep. 2009, 21, 145-152
8. Kimura, Y.; Kido, T.; Takaku, T.; Sumiyoshi, M.; Baba, K. Isolation of an anti-angiogenic substance from Agaricus blazei Murill: Its antitumor and antimetastatic actions Cancer Sci. 2004, 95, 758-764
9. Hetland, G.; Johnson, E.; Lyberg, T.; Bernardshaw, S.; Tryggestad, A. M.; Grinde, B. Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer Scand. J. Immunol. 2008, 68, 363-370
10. Takaku, T.; Kimura, Y.; Okuda, H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action J. Nutr. 2001, 131, 1409-1413
11. Hyodo, I.; Amano, N.; Eguchi, K.; Narabayashi, M.; Imanishi, J.; Hirai, M.; Nakano, T.; Takashima, S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan J. Clin. Oncol. 2005, 23, 2645-2654
12. Kim, Y. W.; Kim, K. H.; Choi, H. J.; Lee, D. S. Anti-diabetic activity of β-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei Biotechnol. Lett. 2005, 27, 483-487
13. Liu, Y.; Fukuwatari, Y.; Okumura, K.; Takeda, K.; Ishibashi, K. I.; Furukawa, M.; Ohno, N.; Mori, K.; Gao, M.; Motoi, M. Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers Evidence Based Complementary Alternat. Med. 2008, 5, 205-219
14. Sorimachi, K.; Ikehara, Y.; Maezato, G.; Okubo, A.; Yamazaki, S.; Akimoto, K.; Niwa, A. Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro Biosci. Biotechnol. Biochem. 2001, 65, 1645-1647
15. Chen, L.; Shao, H. J.; Su, Y. B. Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses Int. Immunopharmacol. 2004, 4, 403-409
16. Chen, L.; Shao, H. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease Vet. Immunol. Immunopathol. 2006, 109, 177-182
17. Hsu, C. H.; Liao, Y. L.; Lin, S. C.; Hwang, K. C.; Chou, P. The mushroom Agaricus blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: A randomized, double-blinded, and placebo-controlled clinical trial J. Altern. Complementary Med. 2007, 13, 97-102
18. Dong, S.; Furutani, Y.; Suto, Y.; Furutani, M.; Zhu, Y.; Yoneyama, M.; Kato, T.; Itabe, H.; Nishikawa, T.; Tomimatsu, H.; Tanaka, T.; Kasanuki, H.; Masaki, T.; Kiyama, R.; Matsuoka, R. Estrogen-like activity and dual roles in cell signaling of an Agaricus blazei Murrill mycelia-dikaryon extract Microbiol. Res. 2012, 167, 231-237
19. Kalin, M. F.; Zumoff, B. Sex hormones and coronary disease: A review of the clinical studies Steroids 1990, 55, 330-352
20. Baker, L.; Meldrum, K. K.; Wang, M.; Sankula, R.; Vanam, R.; Raiesdana, A.; Tsai, B.; Hile, K.; Brown, J. W.; Meldrum, D. R. The role of estrogen in cardiovascular disease J. Surg. Res. 2003, 115, 325-344
21. van Rooij, E.; Fielitz, J.; Sutherland, L. B.; Thijssen, V. L.; Crijns, H. J.; Dimaio, M. J.; Shelton, J.; De Windt, L. J.; Hill, J. A.; Olson, E. N. Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor Circ. Res. 2010, 106, 155-165
22. Dong, S.; Terasaka, S.; Kiyama, R. Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells Environ. Pollut. 2011, 159, 212-218
23. Levin, E. R. Integration of the extranuclear and nuclear actions of estrogen Mol. Endocrinol. 2005, 19, 1951-1959
24. Heldring, N.; Pike, A.; Andersson, S.; Matthews, J.; Cheng, G.; Hartman, J.; Tujague, M.; Ström, A.; Treuter, E.; Warner, M.; Gustafsson, J. A. Estrogen receptors: How do they signal and what are their targets Physiol. Rev. 2007, 87, 905-931
25. Moggs, J. G.; Orphanides, G. Estrogen receptors: Orchestrators of pleiotropic cellular responses EMBO Rep. 2001, 2, 775-781
26. Lorenzo, J. A new hypothesis for how sex steroid hormones regulate bone mass J. Clin. Invest. 2003, 111, 1641-1643
27. Björnström, L.; Sjöberg, M. Estrogen receptor-dependent activation of AP-1 via non-genomic signalling Nucl. Recept. 2004, 2, 3
28. Zivadinovic, D.; Gametchu, B.; Watson, C. S. Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses Breast Cancer Res. 2005, 7, R101-112
29. Liu, Z.; Yu, X.; Shaikh, Z. A. Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium Toxicol. Appl. Pharmacol. 2008, 228, 286-294
30. Bunone, G.; Briand, P. A.; Miksicek, R. J.; Picard, D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation EMBO J. 1996, 15, 2174-2183
31. Cheng, J.; Zhang, C.; Shapiro, D. J. A functional serine 118 phosphorylation site in estrogen receptor-α is required for down-regulation of gene expression by 17β-estradiol and 4-hydroxytamoxifen Endocrinology 2007, 148, 4634-4641
32. Nagashima, T.; Suzuki, T.; Kondo, S.; Kuroki, Y.; Takahashi, K.; Ide, K.; Yumoto, N.; Hasegawa, A.; Toyoda, T.; Kojima, T.; Konagaya, A.; Suzuki, H.; Hayashizaki, Y.; Sakaki, Y.; Hatakeyama, M. Integrative genome-wide expression analysis bears evidence of estrogen receptor-independent transcription in heregulin-stimulated MCF-7 cells PLoS One 2008, 3, e1803
33. Joel, P. B.; Smith, J.; Sturgill, T. W.; Fisher, T. L.; Blenis, J.; Lannigan, D. A. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167 Mol. Cell. Biol. 1998, 18, 1978-1984
34. Keshamouni, V. G.; Mattingly, R. R.; Reddy, K. B. Mechanism of 17β-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta J. Biol. Chem. 2002, 277, 22558-22565
35. Kim, J. K.; Levin, E. R. Estrogen signaling in the cardiovascular system Nucl. Recept. Signaling 2006, 4, e013
36. Filardo, E. J.; Quinn, J. A.; Bland, K. I.; Frackelton, A. R., Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol. Endocrinol. 2000, 14, 1649-1660
37. Razandi, M.; Pedram, A.; Park, S. T.; Levin, E. R. Proximal events in signaling by plasma membrane estrogen receptors J. Biol. Chem. 2003, 278, 2701-2712
38. Suh, Y. G.; Jung, J. K.; Seo, S. Y.; Min, K. H.; Shin, D. Y.; Lee, Y. S.; Kim, S. H.; Park, H. J. Total synthesis of (+)-brefeldin A J. Org. Chem. 2002, 67, 4127-4137
39. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 1990, 82, 1107-1112
40. Terasaka, S.; Aita, Y.; Inoue, A.; Hayashi, S.; Nishigaki, M.; Aoyagi, K.; Sasaki, H.; Wada-Kiyama, Y.; Sakuma, Y.; Akaba, S.; Tanaka, J.; Sone, H.; Yonemoto, J.; Tanji, M.; Kiyama, R. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals Environ. Health Perspect. 2004, 112, 773-781
41. Oseni, T.; Patel, R.; Pyle, J.; Jordan, V. C. Selective estrogen receptor modulators and phytoestrogens Planta Med. 2008, 74, 1656-1665
42. Lóránd, T.; Vigh, E.; Garai, J. Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: Phytoestrogens and xenoestrogens Curr. Med. Chem. 2010, 17, 3542-3574
43. Nilsson, S.; Gustafsson, J.Å. Estrogen receptors: Therapies targeted to receptor subtypes Clin. Pharmacol. Ther. 2011, 89, 44-55
44. Terasaka, S.; Inoue, A.; Tanji, M.; Kiyama, R. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity Toxicol. Lett. 2006, 163, 130-141
45. Tamura, G.; Ando, K.; Suzuki, S.; Takatsuki, A.; Arima, K. Antiviral activity of brefeldin A and verrucarin A J. Antibiot. (Tokyo) 1968, 21, 160-161
46. Klausner, R. D.; Donaldson, J. G.; Lippincott-Schwartz, J.; Brefeldin, A. Insights into the control of membrane traffic and organelle structure J. Cell Biol. 1992, 116, 1071-1080
47. Zeghouf, M.; Guibert, B.; Zeeh, J. C.; Cherfils, J. Arf, Sec7 and Brefeldin A: A model towards the therapeutic inhibition of guanine nucleotide-exchange factors Biochem. Soc. Trans. 2005, 33, 1265-1268
48. Buache, E.; Etique, N.; Alpy, F.; Stoll, I.; Muckensturm, M.; Reina-San-Martin, B.; Chenard, M. P.; Tomasetto, C.; Rio, M. C. Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice Oncogene 2011, 30 (29) 3261-3273
49. Hoffmann, W. Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution Cell. Mol. Life Sci. 2005, 62 (24) 2932-2938
50. Largeteau, M. L.; Llarena-Hernández, R. C.; Regnault-Roger, C.; Savoie, J. M. The medicinal Agaricus mushroom cultivated in Brazil: Biology, cultivation and non-medicinal valorisation Appl. Microbiol. Biotechnol. 2011, 92, 897-907
51. Argade, A. B.; Devraj, R.; Vroman, J. A.; Haugwitz, R. D.; Hollingshead, M.; Cushman, M. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities J. Med. Chem. 1998, 41, 3337-3346
52. Wang, Y. J.; Xue, F.; Wu, Y. F.; Xue, Y. P.; Zheng, Y. G. Development of macrolide lactone antibiotic brefeldin A fermentation process with Eupenicillium brefeldianum ZJB082702 J. Biosci. Bioeng. 2012, 114, 262-267
53. Hao, J.; Sun, Y.; Wang, Q.; Tong, X.; Zhang, H.; Zhang, Q. Effect and mechanism of penetration enhancement of organic base and alcohol on glycyrrhetinic acid in vitro Int. J. Pharm. 2010, 399, 102-108
54. Sui, X.; Wei, W.; Yang, L.; Zu, Y.; Zhao, C.; Zhang, L.; Yang, F.; Zhang, Z. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process Int. J. Pharm. 2012, 423, 471-479